Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
| ▸ | ACACA | Q13085 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2134102 | 0.98 | EPHX1 (0.42) | EPHX1FFAR1CPT2TDP1ACACB | |
| SCHEMBL2139066 | 0.95 | EPHX1 (0.37) | EPHX1ALDH1A1HSD17B10 | |
| SCHEMBL2135625 | 0.87 | EPHX1 (0.41) | EPHX1ALDH1A1HSD17B10 | |
| SCHEMBL2138737 | 0.86 | EPHX1 (0.43) | EPHX1FFAR1CPT2TDP1ACACB | |
| SCHEMBL2131384 | 0.86 | EPHX1 (0.43) | EPHX1FFAR1CPT2TDP1ACACB | |
| SCHEMBL2135833 | 0.84 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL2133406 | 0.83 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL2136683 | 0.83 | EPHX1 (0.41) | EPHX1 | |
| SCHEMBL2134674 | 0.83 | EPHX1 (0.41) | EPHX1 | |
| SCHEMBL2136608 | 0.81 | EPHX1 (0.38) | EPHX1ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | GRHPR, AKR7A2, FAR1 | EPHX1 2018/4885FFAR1 18/4885CPT2 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.